12.
Aleix Prat #PrecisionOncology
@prat_aleix
Here is a video explaining the HARMONIA phase III clinical trial to begin Q1 2022
HR+/HER2-neg advanced breast… twitter.com/i/web/status/1…
HR+/HER2-neg advanced breast… twitter.com/i/web/status/1…
13.
Aleix Prat #PrecisionOncology
@prat_aleix
1/6 Our new clinical case report in @FrontiersIn
bit.ly/3zBmDQl
HR+ -> TNBC/PDL1-neg -> ctDNA response… twitter.com/i/web/status/1…
bit.ly/3zBmDQl
HR+ -> TNBC/PDL1-neg -> ctDNA response… twitter.com/i/web/status/1…
14.
15.
16.
17.
18.
Aleix Prat
@prat_aleix
Adjuvant Aromatase-Inhibitor Therapy in Breast Cancer by @MichaelGnant @NEJM
In postmenopausal women with HR+… twitter.com/i/web/status/1…
In postmenopausal women with HR+… twitter.com/i/web/status/1…
Aleix Prat
@prat_aleix
more evidence that gene expression is needed in advanced breast cancer, here TNBC Impassion 130.
Basal-like is a… twitter.com/i/web/status/1…
Basal-like is a… twitter.com/i/web/status/1…
Aleix Prat
@prat_aleix
Did you already register to #SOLTI's #UpToDateSummit 2021?
Latest advances in breast cancer: from molecular data t… twitter.com/i/web/status/1…
Latest advances in breast cancer: from molecular data t… twitter.com/i/web/status/1…
Aleix Prat
@prat_aleix
Apparently, I'm a PhD now...and it feels GOOD
THANK YOU to my mentors, to all the people who helped me, worked wi… twitter.com/i/web/status/1…
THANK YOU to my mentors, to all the people who helped me, worked wi… twitter.com/i/web/status/1…
Retweet of status by @FrancescoSche20
Aleix Prat
@prat_aleix
HER2+ BC is a heterogenous disease. In particular, HR-expression defines 2 very different entities:
HER2+/HR- dis… twitter.com/i/web/status/1…
HER2+/HR- dis… twitter.com/i/web/status/1…
Retweet of status by @PTarantinoMD
...but wait! There's more!
12.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
